Among adults with blood cancers receiving end-of-life hospice care at home, a blood transfusion based on symptoms, not blood tests, was feasible and safe, with…
Myeloma
I watch my mum reach for her favorite scarf and carefully drape it around her shoulders. The gesture is ordinary, almost automatic, yet in this…
Darzalex Faspro, an under-the-skin injection therapy, was associated with better survival than Darzalex, an intravenous (IV) infusion therapy, among people with multiple…
I catch myself scanning the room for hazards before I even sit down. The loose edge of a rug, the distance between the chair and…
Abbvie is asking the U.S. Food and Drug Administration (FDA) to approve its next-generation therapy etentamig for people with multiple myeloma whose cancer…
A couple of weeks ago, I wrote about how post-vaccine fatigue had me thinking about multiple myeloma relapse. I mentioned how worried my…
A Phase 2 trial of a four-drug regimen including Sarclisa Escena (isatuximab-irfc) showed promising treatment responses in people ages 65 and older with newly…
I stand in the doorway and hesitate before stepping outside. My mum is resting comfortably. The medication has settled her pain for now, and her…
The European Commission has cleared Tecvayli (teclistamab-cqyv) as a monotherapy, meaning it can be given on its own, for adults whose myeloma returned or…
In the spirit of Halloween, I’m offering up the scariest costume I’ve ever worn. It was for a work party a couple of years ago.
Recent Posts
- Study finds home transfusions safe in hospice care for blood cancer
- Small acts of defiance are the ways we push back against disease
- Under-the-skin myeloma treatment linked to better survival in study
- Add-on therapy shows promise for hard-to-treat AML
- When the caregiver role starts to feel like a second skin